136 related articles for article (PubMed ID: 16337895)
1. A case of rabbit syndrome treated with quetiapine.
Altindag A; Yanik M
Eur Psychiatry; 2005 Dec; 20(8):574-5. PubMed ID: 16337895
[TBL] [Abstract][Full Text] [Related]
2. Tardive dyskinesia with quetiapine.
Ghelber D; Belmaker RH
Am J Psychiatry; 1999 May; 156(5):796-7. PubMed ID: 10327920
[No Abstract] [Full Text] [Related]
3. Tardive dyskinesia in a patient treated with quetiapine.
Rizos E; Douzenis A; Gournellis R; Christodoulou C; Lykouras LP
World J Biol Psychiatry; 2009; 10(1):54-7. PubMed ID: 19673087
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia.
Alptekin K; Kivircik BB
Int Clin Psychopharmacol; 2002 Sep; 17(5):263-4. PubMed ID: 12177588
[TBL] [Abstract][Full Text] [Related]
5. A case of tardive dystonia successfully managed with quetiapine.
Sasaki Y; Kusumi I; Koyama T
J Clin Psychiatry; 2004 Apr; 65(4):583-4. PubMed ID: 15119928
[No Abstract] [Full Text] [Related]
6. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.
Emsley R; Turner HJ; Schronen J; Botha K; Smit R; Oosthuizen PP
J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258
[TBL] [Abstract][Full Text] [Related]
7. Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: a report of 2 cases.
Gourzis P; Polychronopoulos P; Papapetropoulos S; Assimakopoulos K; Argyriou AA; Beratis S
Clin Neuropharmacol; 2005; 28(4):195-6. PubMed ID: 16062102
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic drugs and schizophrenia.
Essock SM; Covell NH; Jackson CT
N Engl J Med; 2006 Jan; 354(3):298-300; author reply 298-300. PubMed ID: 16422020
[No Abstract] [Full Text] [Related]
9. Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity.
Bressan RA; Jones HM; Pilowsky LS
J Psychopharmacol; 2004 Mar; 18(1):124-7. PubMed ID: 15107196
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
11. Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine.
Vesely C; Küfferle B; Brücke T; Kasper S
Int Clin Psychopharmacol; 2000 Jan; 15(1):57-60. PubMed ID: 10836289
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.
Nelson MW; Reynolds RR; Kelly DL; Conley RR
Clin Neuropharmacol; 2003; 26(6):297-8. PubMed ID: 14646608
[TBL] [Abstract][Full Text] [Related]
13. Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment.
Schwartz M; Weller B; Erdreich M; Sharf B
J Clin Psychiatry; 1995 May; 56(5):212. PubMed ID: 7737962
[No Abstract] [Full Text] [Related]
14. Quetiapine treatment of children with Tourette's syndrome: report of two cases.
Párraga HC; Párraga MI; Woodward RL; Fenning PA
J Child Adolesc Psychopharmacol; 2001; 11(2):187-91. PubMed ID: 11436959
[TBL] [Abstract][Full Text] [Related]
15. The scourge of EPS: have atypical antipsychotics solved the problem?
J Clin Psychiatry; 2000 Dec; 61(12):955-62. PubMed ID: 11206607
[No Abstract] [Full Text] [Related]
16. Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine.
Bouckaert F; Herman G; Peuskens J
Int J Geriatr Psychiatry; 2005 Mar; 20(3):287-8. PubMed ID: 15770692
[No Abstract] [Full Text] [Related]
17. Reduction of tardive dyskinesia with quetiapine.
Farah A
Schizophr Res; 2001 Mar; 47(2-3):309-10. PubMed ID: 11322143
[No Abstract] [Full Text] [Related]
18. Quetiapine-related tardive dyskinesia.
Ghaemi SN; Ko JY
Am J Psychiatry; 2001 Oct; 158(10):1737. PubMed ID: 11579018
[No Abstract] [Full Text] [Related]
19. Treatment of depressive mood in schizophrenia with the atypical antipsychotic quetiapine.
Khouzam HR
Depress Anxiety; 2000; 11(2):80-2. PubMed ID: 10812533
[TBL] [Abstract][Full Text] [Related]
20. FDA advisers wary of expanding quetiapine use: clinicians air concerns about metabolic effects, tardive dyskinesia.
Traynor K
Am J Health Syst Pharm; 2009 May; 66(10):880, 882. PubMed ID: 19420301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
